ZNF677 and metastatic malignant neoplasm in the lymph nodes: This suggests that loss of ZNF677 expression is a useful biomarker to identify the high risk population with potential lymph node metastasis and acts as an independent risk factor for predicting lymph node involvement in CRC patients.